DuPont Sees Growth in Nutrition & Biosciences Segments

DuPont has released its 2020 first quarter results, noting substantial growth in its Nutrition & Biosciences segment, with its probiotics section seeing its strongest growth period to date.

The company’s Nutrition & Biosciences segment reported net sales of USD1.5bn, up 1% from the year-ago period. Organic sales were up 3% with a 2% price improvement and a 1% volume gain. Currency was a 2% headwind, DuPont highlights.

Sales gains were led by Health & Biosciences with high-single digit growth versus the same period last year. The probiotics business recorded its strongest quarter ever with mid-teens growth as key initiatives to strengthen the North America market were implemented and consumer demand for immune health strengthened globally.

The company reports that net sales totaled USD5.2bn, down 4% versus the year-ago period. On an organic basis, 3% growth in Nutrition & Biosciences was more than offset by organic sales declines in the other segments.